Abstract:The linear sequence of amino acids in a protein folds into a 3D structure to execute protein activity and function, but it is still challenging to profile the 3D structure at the proteome scale. Here, we present a method of native protein tandem mass tag (TMT) profiling of Lys accessibility and its application to investigate structural alterations in human brain specimens of Alzheimer's disease (AD). In this method, proteins are extracted under a native condition, labeled by TMT reagents, followed by trypsin digestion and peptide analysis using two-dimensional liquid chromatography and tandem mass spectrometry (LC/LC-MS/MS). The method quantifies Lys labeling efficiency to evaluate its accessibility on the protein surface, which may be affected by protein conformations, protein modifications, and/or other molecular interactions. We systematically optimized the amount of TMT reagents, reaction time, and temperature and then analyzed protein samples under multiple conditions, including different labeling time (5 and 30 min), heat treatment, AD and normal human cases. The experiment profiled 15370 TMT-labeled peptides in 4475 proteins. As expected, the heat treatment led to extensive changes in protein conformations, with 17% of the detected proteome displaying differential labeling. Compared to the normal controls, AD brain showed different Lys accessibility of tau and RNA splicing complexes, which are the hallmarks of AD pathology, as well as proteins involved in transcription, mitochondrial, and synaptic functions. To eliminate the possibility that the observed differential Lys labeling was caused by protein level change, the whole proteome was quantified with standard TMT-LC/LC-MS/MS for normalization. Thus, this native protein TMT method enables the proteome-wide measurement of Lys accessibility, representing a straightforward strategy to explore protein structure in any biological system.

Using in vivo intact structure for system-wide quantitative analysis of changes in proteins

Global Profiling of Lysine Accessibility to Evaluate Protein Structure Changes in Alzheimer's Disease

Proteomics of Spatially Identified Tissues in Whole Organs

Exploring dimethylsulfate for in vivo proteome footprinting

Unveiling the Structural Proteome of an Alzheimer's Disease Rat Brain Model

Structural Proteomic Profiling of Cerebrospinal Fluids to Reveal Novel Conformational Biomarkers for Alzheimer's Disease

DiLeu Isobaric Labeling Coupled with Limited Proteolysis Mass Spectrometry for High-Throughput Profiling of Protein Structural Changes in Alzheimer's Disease

Quantitative analysis of global protein stability rates in tissues

Determining Composition of Micron-Scale Protein Deposits in Neurodegenerative Disease by Spatially Targeted Optical Microproteomics

Quantitative structural proteomics in living cells by covalent protein painting

Imaging Complex Protein Metabolism in Live Organisms by Stimulated Raman Scattering Microscopy with Isotope Labeling

In-Depth Proteomic Analysis of De Novo Proteome in a Mouse Model of Alzheimer’s Disease

The path forward for protein footprinting, covalent labeling, and mass spectrometry‐based protein conformational analyses

Dynamic 3D proteomes reveal protein functional alterations at high resolution in situ

In Situ Living Cell Protein Analysis by Single-Step Mass Spectrometry

Measuring protein structural changes on a proteome-wide scale using limited proteolysis-coupled mass spectrometry

Large-Scale Quantitative Cross-Linking and Mass Spectrometry Provides New Insight on Protein Conformational Plasticity within Organelles, Cells, and Tissues

Tissue Proteomics Using Chemical Immobilization and Mass Spectrometry

Analysis of Brain Protein Stability Changes in a Mouse Model of Alzheimer's Disease

Real-Time Monitoring Conformational Changes of a Intrinsically Disordered Protein with Aerolysin Nanopore

Native Ambient Mass Spectrometry Enables Analysis of Intact Endogenous Protein Assemblies up to 145 kDa Directly from Tissue